3-151340653-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022788.5(P2RY12):c.-72T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.849 in 152,618 control chromosomes in the GnomAD database, including 54,992 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.85 ( 54843 hom., cov: 33)
Exomes 𝑓: 0.83 ( 149 hom. )
Consequence
P2RY12
NM_022788.5 5_prime_UTR
NM_022788.5 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.10
Genes affected
P2RY12 (HGNC:18124): (purinergic receptor P2Y12) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
MED12L (HGNC:16050): (mediator complex subunit 12L) The protein encoded by this gene is part of the Mediator complex, which is involved in transcriptional coactivation of nearly all RNA polymerase II-dependent genes. The Mediator complex links gene-specific transcriptional activators with the basal transcription machinery. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.878 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RY12 | NM_022788.5 | c.-72T>C | 5_prime_UTR_variant | 2/3 | ENST00000302632.4 | NP_073625.1 | ||
MED12L | NM_001393769.1 | c.2251-9406A>G | intron_variant | ENST00000687756.1 | NP_001380698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RY12 | ENST00000302632.4 | c.-72T>C | 5_prime_UTR_variant | 2/3 | 1 | NM_022788.5 | ENSP00000307259 | P1 | ||
MED12L | ENST00000687756.1 | c.2251-9406A>G | intron_variant | NM_001393769.1 | ENSP00000508695 | A2 |
Frequencies
GnomAD3 genomes AF: 0.849 AC: 129068AN: 152064Hom.: 54813 Cov.: 33
GnomAD3 genomes
AF:
AC:
129068
AN:
152064
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.828 AC: 361AN: 436Hom.: 149 Cov.: 0 AF XY: 0.837 AC XY: 221AN XY: 264
GnomAD4 exome
AF:
AC:
361
AN:
436
Hom.:
Cov.:
0
AF XY:
AC XY:
221
AN XY:
264
Gnomad4 ASJ exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.849 AC: 129152AN: 152182Hom.: 54843 Cov.: 33 AF XY: 0.851 AC XY: 63317AN XY: 74402
GnomAD4 genome
AF:
AC:
129152
AN:
152182
Hom.:
Cov.:
33
AF XY:
AC XY:
63317
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2910
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at